2023 Q2 Form 10-Q Financial Statement

#000157694023000034 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $844.2M $753.0M
YoY Change -27.61% -25.91%
Cost Of Revenue $657.2M $601.4M
YoY Change -20.14% -15.29%
Gross Profit $187.0M $151.6M
YoY Change -45.52% -50.53%
Gross Profit Margin 22.15% 20.13%
Selling, General & Admin $105.1M $98.31M
YoY Change -3.7% -3.27%
% of Gross Profit 56.22% 64.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.621M $3.292M
YoY Change 31.86% 26.32%
% of Gross Profit 1.94% 2.17%
Operating Expenses $105.1M $98.31M
YoY Change -3.7% -3.27%
Operating Profit $81.86M $53.29M
YoY Change -65.03% -73.98%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$13.11M $1.498M
YoY Change 110.06% -273.78%
Pretax Income $68.75M $44.01M
YoY Change -67.82% -76.69%
Income Tax $17.30M $10.70M
% Of Pretax Income 25.17% 24.31%
Net Earnings $51.45M $33.31M
YoY Change -67.58% -76.62%
Net Earnings / Revenue 6.09% 4.42%
Basic Earnings Per Share $1.61 $1.04
Diluted Earnings Per Share $1.60 $1.04
COMMON SHARES
Basic Shares Outstanding 32.03M 31.77M
Diluted Shares Outstanding 32.25M 32.12M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $350.5M $405.7M
YoY Change 349.28% 94.08%
Cash & Equivalents $350.5M $405.7M
Short-Term Investments
Other Short-Term Assets $25.20M $28.92M
YoY Change -21.02% -19.59%
Inventory $2.856B $2.741B
Prepaid Expenses
Receivables $59.99M $52.79M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.292B $3.229B
YoY Change 3.82% 8.66%
LONG-TERM ASSETS
Property, Plant & Equipment $32.66M $33.02M
YoY Change 19.63% 18.81%
Goodwill $30.40M $30.40M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $62.48M $48.52M
YoY Change -48.64% -35.82%
Total Long-Term Assets $564.6M $484.4M
YoY Change -6.17% -7.61%
TOTAL ASSETS
Total Short-Term Assets $3.292B $3.229B
Total Long-Term Assets $564.6M $484.4M
Total Assets $3.857B $3.713B
YoY Change 2.22% 6.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $146.6M $106.5M
YoY Change 24.85% 16.4%
Accrued Expenses $266.4M $256.0M
YoY Change -22.69% -21.0%
Deferred Revenue
YoY Change
Short-Term Debt $191.0M $149.8M
YoY Change -8.6% -22.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $603.9M $513.0M
YoY Change -9.98% -21.64%
LONG-TERM LIABILITIES
Long-Term Debt $1.031B $1.027B
YoY Change -10.42% 1.55%
Other Long-Term Liabilities $0.00 $1.692M
YoY Change
Total Long-Term Liabilities $1.031B $1.028B
YoY Change -10.42% 1.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $603.9M $513.0M
Total Long-Term Liabilities $1.031B $1.028B
Total Liabilities $1.635B $1.541B
YoY Change -10.26% -7.46%
SHAREHOLDERS EQUITY
Retained Earnings $1.635B $1.591B
YoY Change 20.72% 32.34%
Common Stock $587.2M $580.8M
YoY Change -1.65% -7.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.222B $2.172B
YoY Change
Total Liabilities & Shareholders Equity $3.857B $3.713B
YoY Change 2.22% 6.22%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $51.45M $33.31M
YoY Change -67.58% -76.62%
Depreciation, Depletion And Amortization $3.621M $3.292M
YoY Change 31.86% 26.32%
Cash From Operating Activities -$58.56M $191.3M
YoY Change -72.42% 74.84%
INVESTING ACTIVITIES
Capital Expenditures $3.893M $4.820M
YoY Change -232.24% -17.48%
Acquisitions
YoY Change
Other Investing Activities -$23.78M -$152.0K
YoY Change 37.86% -79.73%
Cash From Investing Activities -$27.67M -$20.94M
YoY Change 37.04% 311.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 34.91M -58.28M
YoY Change -68.87% -72.04%
NET CHANGE
Cash From Operating Activities -58.56M 191.3M
Cash From Investing Activities -27.67M -20.94M
Cash From Financing Activities 34.91M -58.28M
Net Change In Cash -51.32M 112.1M
YoY Change -57.36% -207.72%
FREE CASH FLOW
Cash From Operating Activities -$58.56M $191.3M
Capital Expenditures $3.893M $4.820M
Free Cash Flow -$62.45M $186.5M
YoY Change -70.17% 80.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2022Q1 ccs Payments For Self Insurance
PaymentsForSelfInsurance
CY2022Q1 ccs Self Insurance Adjustment
SelfInsuranceAdjustment
CY2022Q1 ccs Self Insurance Adjustment
SelfInsuranceAdjustment
CY2023Q1 ccs Self Insurance Adjustment
SelfInsuranceAdjustment
CY2023Q1 ccs Self Insurance Adjustment
SelfInsuranceAdjustment
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001576940
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssets
CY2023Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssets
CY2022Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2023Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36491
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Century Communities, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0521411
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8390 East Crescent Parkway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
CY2023Q1 dei City Area Code
CityAreaCode
303
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
770-8300
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
CCS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32025879
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32025785
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31772791
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
405722000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
296724000
CY2023Q1 ccs Cash Held In Escrow
CashHeldInEscrow
12691000
CY2022Q4 ccs Cash Held In Escrow
CashHeldInEscrow
56569000
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
52787000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
52797000
CY2023Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
2741187000
CY2022Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
2830645000
CY2023Q1 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
155732000
CY2022Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
203558000
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
260505000
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
250535000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33019000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31688000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
20939000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
20856000
CY2023Q1 us-gaap Goodwill
Goodwill
30395000
CY2022Q4 us-gaap Goodwill
Goodwill
30395000
CY2023Q1 us-gaap Assets
Assets
3712977000
CY2022Q4 us-gaap Assets
Assets
3773767000
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
106525000
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
106926000
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
258412000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
299588000
CY2023Q1 us-gaap Notes Payable
NotesPayable
1026615000
CY2022Q4 us-gaap Notes Payable
NotesPayable
1019412000
CY2023Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
149784000
CY2022Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
197626000
CY2023Q1 us-gaap Liabilities
Liabilities
1541336000
CY2022Q4 us-gaap Liabilities
Liabilities
1623552000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32025785
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31772791
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
320000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
318000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
580489000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
584803000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1590832000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1565094000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2171641000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2150215000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3712977000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3773767000
CY2023Q1 us-gaap Revenues
Revenues
752990000
CY2022Q1 us-gaap Revenues
Revenues
1016350000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
98313000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101639000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1498000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-862000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44009000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
188776000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10698000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46280000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
142496000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.25
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.20
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31914414
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33530610
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32117082
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33942234
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
142496000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3292000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2606000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5360000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4064000
CY2023Q1 ccs Fair Value Of Loans Held For Sale And Other
FairValueOfLoansHeldForSaleAndOther
205000
CY2022Q1 ccs Fair Value Of Loans Held For Sale And Other
FairValueOfLoansHeldForSaleAndOther
4443000
CY2023Q1 ccs Abandonment Of Lot Option Contracts
AbandonmentOfLotOptionContracts
638000
CY2022Q1 ccs Abandonment Of Lot Option Contracts
AbandonmentOfLotOptionContracts
875000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-83000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-33000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-198000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-384000
CY2023Q1 ccs Increase Decrease In Cash Held In Escrow
IncreaseDecreaseInCashHeldInEscrow
-43878000
CY2022Q1 ccs Increase Decrease In Cash Held In Escrow
IncreaseDecreaseInCashHeldInEscrow
-7085000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4106000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-90152000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
222863000
CY2023Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-48241000
CY2022Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-144361000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8247000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28959000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-401000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6841000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-41714000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
52239000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
191334000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
109433000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4820000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5841000
CY2023Q1 ccs Expenditures Related To Rental Properties
ExpendituresRelatedToRentalProperties
16268000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-152000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-750000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20936000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5091000
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
141500000
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
141500000
CY2023Q1 us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
7137000
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3032000
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
16863000
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3364000
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5235000
CY2023Q1 ccs Proceeds From Repayments Of Mortgage Credit Facility
ProceedsFromRepaymentsOfMortgageCreditFacility
-47842000
CY2022Q1 ccs Proceeds From Repayments Of Mortgage Credit Facility
ProceedsFromRepaymentsOfMortgageCreditFacility
-138848000
CY2023Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
9880000
CY2022Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
12138000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
62377000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7365000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6657000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-34000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58282000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-208426000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
112116000
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
18
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-104084000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
308492000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
322241000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
420608000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218157000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-893000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
405722000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
209046000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
14886000
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
9111000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
420608000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218157000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2150215000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-9880000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5360000
CY2023Q1 ccs Cash Dividends Declared And Dividend Equivalents
CashDividendsDeclaredAndDividendEquivalents
-7365000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2171641000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1764508000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-12138000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
62377000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4064000
CY2022Q1 ccs Cash Dividends Declared And Dividend Equivalents
CashDividendsDeclaredAndDividendEquivalents
-6657000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-34000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
142496000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1829862000
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
18
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates. </span>
CY2023Q1 us-gaap Revenues
Revenues
752990000
CY2022Q1 us-gaap Revenues
Revenues
1016350000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44009000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
188776000
CY2023Q1 us-gaap Assets
Assets
3712977000
CY2022Q4 us-gaap Assets
Assets
3773767000
CY2023Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1115524000
CY2022Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1213919000
CY2023Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1559679000
CY2022Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1554951000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
65984000
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
61775000
CY2023Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
2741187000
CY2022Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
2830645000
CY2023Q1 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
155700000
CY2022Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
203600000
CY2023Q1 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
153800000
CY2022Q4 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
202000000.0
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1800000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
10400000
CY2022Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
9700000
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
98900000
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
68100000
CY2023Q1 us-gaap Prepaid Insurance
PrepaidInsurance
28921000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
31716000
CY2023Q1 ccs Lot Option And Escrow Deposits
LotOptionAndEscrowDeposits
42364000
CY2022Q4 ccs Lot Option And Escrow Deposits
LotOptionAndEscrowDeposits
48354000
CY2023Q1 ccs Performance Deposits
PerformanceDeposits
12835000
CY2022Q4 ccs Performance Deposits
PerformanceDeposits
12626000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
14886000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11768000
CY2023Q1 ccs Multi Family Rental Properties Under Construction
MultiFamilyRentalPropertiesUnderConstruction
73475000
CY2022Q4 ccs Multi Family Rental Properties Under Construction
MultiFamilyRentalPropertiesUnderConstruction
56615000
CY2023Q1 ccs Mortgage Loans Held For Investment Fair Value
MortgageLoansHeldForInvestmentFairValue
20078000
CY2022Q4 ccs Mortgage Loans Held For Investment Fair Value
MortgageLoansHeldForInvestmentFairValue
18875000
CY2023Q1 ccs Mortgage Loans Held For Investment Amortized Cost
MortgageLoansHeldForInvestmentAmortizedCost
6420000
CY2022Q4 ccs Mortgage Loans Held For Investment Amortized Cost
MortgageLoansHeldForInvestmentAmortizedCost
6574000
CY2023Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
23901000
CY2022Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
24164000
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
3082000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
1958000
CY2023Q1 us-gaap Other Assets
OtherAssets
34543000
CY2022Q4 us-gaap Other Assets
OtherAssets
37885000
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
260505000
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
250535000
CY2023Q1 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
16749000
CY2022Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
17903000
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12331000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13136000
CY2023Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
19076000
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
16998000
CY2023Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
33107000
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
80415000
CY2023Q1 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
130610000
CY2022Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
128483000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
13753000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10670000
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
677000
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
1692000
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1526000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
30417000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
30457000
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
258412000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
299588000
CY2023Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-500000
CY2022Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-600000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13136000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13343000
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1829000
CY2022Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1902000
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2176000
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1185000
CY2023Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-458000
CY2022Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-557000
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12331000
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13503000
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
16998000
CY2021Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
5103000
CY2023Q1 ccs Self Insurance Expense Provisions
SelfInsuranceExpenseProvisions
2115000
CY2022Q1 ccs Self Insurance Expense Provisions
SelfInsuranceExpenseProvisions
2372000
CY2023Q1 ccs Payments For Self Insurance
PaymentsForSelfInsurance
-37000
CY2023Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
19076000
CY2022Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
7475000
CY2023Q1 us-gaap Notes Payable
NotesPayable
1026615000
CY2022Q4 us-gaap Notes Payable
NotesPayable
1019412000
CY2023Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
149784000
CY2022Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
197626000
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1176399000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1217038000
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
61775000
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
53379000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
14016000
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
14019000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
9807000
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
12146000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
65984000
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
55252000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.007
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2023Q1 ccs Difference Between Estimated Annual Tax Rate And Prior Year Effective Tax Rate
DifferenceBetweenEstimatedAnnualTaxRateAndPriorYearEffectiveTaxRate
0.0260
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10700000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46300000
CY2023Q1 ccs Mortgage Servicing Cost To Service
MortgageServicingCostToService
0.073
CY2022 ccs Mortgage Servicing Cost To Service
MortgageServicingCostToService
0.072
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5400000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4100000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000.0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32000000.0
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32000000.0
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31800000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31800000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
4500000
CY2022Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
1000000.0
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
62400000
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
61.52
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9900000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
12100000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
142496000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31914414
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33530610
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
202668
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
411624
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32117082
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33942234
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.25
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.20
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
CY2023Q1 ccs Land Development Performance Obligations Letters Of Credit And Performance Bonds
LandDevelopmentPerformanceObligationsLettersOfCreditAndPerformanceBonds
570800000
CY2022Q4 ccs Land Development Performance Obligations Letters Of Credit And Performance Bonds
LandDevelopmentPerformanceObligationsLettersOfCreditAndPerformanceBonds
574800000

Files In Submission

Name View Source Status
ccs-20230331_cal.xml Edgar Link unprocessable
0001576940-23-000034-index-headers.html Edgar Link pending
0001576940-23-000034-index.html Edgar Link pending
0001576940-23-000034.txt Edgar Link pending
0001576940-23-000034-xbrl.zip Edgar Link pending
ccs-20230331.xsd Edgar Link pending
ccs-20230331x10q.htm Edgar Link pending
ccs-20230331xex22_1.htm Edgar Link pending
ccs-20230331xex31_1.htm Edgar Link pending
ccs-20230331xex31_2.htm Edgar Link pending
ccs-20230331xex31_3.htm Edgar Link pending
ccs-20230331xex32_1.htm Edgar Link pending
ccs-20230331xex32_2.htm Edgar Link pending
ccs-20230331xex32_3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
ccs-20230331_def.xml Edgar Link unprocessable
ccs-20230331_pre.xml Edgar Link unprocessable
ccs-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ccs-20230331x10q_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending